BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12172978)

  • 1. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
    Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
    Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of alternating administration of carboplatin and doxorubicin in dogs with microscopic metastases after amputation for appendicular osteosarcoma: 50 cases (1999-2006).
    Bacon NJ; Ehrhart NP; Dernell WS; Lafferty M; Withrow SJ
    J Am Vet Med Assoc; 2008 May; 232(10):1504-10. PubMed ID: 18479240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of single-agent carboplatin as adjuvant or neoadjuvant therapy in conjunction with amputation for appendicular osteosarcoma in dogs.
    Phillips B; Powers BE; Dernell WS; Straw RC; Khanna C; Hogge GS; Vail DM
    J Am Anim Hosp Assoc; 2009; 45(1):33-8. PubMed ID: 19122062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
    McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
    J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991 to 1993).
    Bergman PJ; MacEwen EG; Kurzman ID; Henry CJ; Hammer AS; Knapp DW; Hale A; Kruth SA; Klein MK; Klausner J; Norris AM; McCaw D; Straw RC; Withrow SJ
    J Vet Intern Med; 1996; 10(2):76-81. PubMed ID: 8683484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
    Kozicki AR; Robat C; Chun R; Kurzman ID
    Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma.
    Selmic LE; Burton JH; Thamm DH; Withrow SJ; Lana SE
    J Vet Intern Med; 2014; 28(2):554-63. PubMed ID: 24512451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.
    Heishima K; Meuten T; Yoshida K; Mori T; Thamm DH
    BMC Vet Res; 2019 Jan; 15(1):39. PubMed ID: 30683101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
    Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
    J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
    Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
    Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.
    Kurzman ID; MacEwen EG; Rosenthal RC; Fox LE; Keller ET; Helfand SC; Vail DM; Dubielzig RR; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Dec; 1(12):1595-601. PubMed ID: 9815961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
    Kent MS; Strom A; London CA; Seguin B
    J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.
    London CA; Gardner HL; Mathie T; Stingle N; Portela R; Pennell ML; Clifford CA; Rosenberg MP; Vail DM; Williams LE; Cronin KL; Wilson-Robles H; Borgatti A; Henry CJ; Bailey DB; Locke J; Northrup NC; Crawford-Jakubiak M; Gill VL; Klein MK; Ruslander DM; Thamm DH; Phillips B; Post G
    PLoS One; 2015; 10(4):e0124889. PubMed ID: 25923466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
    Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
    J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.
    Gieger TL; Nettifee-Osborne J; Hallman B; Johannes C; Clarke D; Nolan MW; Williams LE
    Can J Vet Res; 2017 Jul; 81(3):199-205. PubMed ID: 28725110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome in dogs treated with adjuvant carboplatin for appendicular osteosarcoma: 65 cases (1996-2006).
    Saam DE; Liptak JM; Stalker MJ; Chun R
    J Am Vet Med Assoc; 2011 Jan; 238(2):195-206. PubMed ID: 21235373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
    LeBlanc AK; Mazcko CN; Cherukuri A; Berger EP; Kisseberth WC; Brown ME; Lana SE; Weishaar K; Flesner BK; Bryan JN; Vail DM; Burton JH; Willcox JL; Mutsaers AJ; Woods JP; Northrup NC; Saba C; Curran KM; Leeper H; Wilson-Robles H; Wustefeld-Janssens BG; Lindley S; Smith AN; Dervisis N; Klahn S; Higginbotham ML; Wouda RM; Krick E; Mahoney JA; London CA; Barber LG; Balkman CE; McCleary-Wheeler AL; Suter SE; Martin O; Borgatti A; Burgess K; Childress MO; Fidel JL; Allstadt SD; Gustafson DL; Selmic LE; Khanna C; Fan TM
    Clin Cancer Res; 2021 Jun; 27(11):3005-3016. PubMed ID: 33753454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canine osteosarcoma: amputation and chemoimmunotherapy.
    MacEwen EG; Kurzman ID
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):123-33. PubMed ID: 8825571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine osteosarcoma: amputation and chemotherapy.
    Berg J
    Vet Clin North Am Small Anim Pract; 1996 Jan; 26(1):111-21. PubMed ID: 8825570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990).
    Thompson JP; Fugent MJ
    J Am Vet Med Assoc; 1992 Feb; 200(4):531-3. PubMed ID: 1559895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.